Bristol-Myers Squibb Earnings, Revenue Beat in Q1
2022.04.29 14:36
Bristol-Myers Squibb Earnings, Revenue Beat in Q1
Investing.com – Bristol-Myers Squibb (NYSE:BMY) reported on Friday first quarter earnings that beat analysts’ forecasts and revenue that topped expectations.
Bristol-Myers Squibb announced earnings per share of $1.96 on revenue of $11.65B. Analysts polled by Investing.com anticipated EPS of $1.91 on revenue of $11.35B.
Bristol-Myers Squibb shares are down 4% from the beginning of the year, still down 1.24% from its 52 week high of $78.17 set on April 21. They are outperforming the S&P Global 100 which is down 10.1% from the start of the year.
Bristol-Myers Squibb follows other major Healthcare sector earnings this month
Bristol-Myers Squibb’s report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
